Bacterial meningitis associated with infliximab

Pharmacy World and Science

Volumn 28, Issue 3, 2006, Pages 123-125

  Farah, Raymond ^a   Lisitsin, Svetlana ^a   Shay, Moshe ^a  

^a WESTERN GALILEE HOSPITAL   (Israel)

Author keywords

Infliximab; Meningitis; TNF ; Wegener's granulomatosis

Indexed keywords

AMPICILLIN; AZATHIOPRINE; CEFTRIAXONE; INFLIXIMAB; PREDNISONE; RIFAMPICIN; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ADULT; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM ISOLATION; BRAIN EDEMA; CASE REPORT; CEREBROSPINAL FLUID CULTURE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; FEMALE; FEVER; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MENTAL DISEASE; MUSCLE STIFFNESS; NECK MUSCLE; SEPSIS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BRAIN EDEMA; FEMALE; HUMANS; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; STREPTOCOCCUS PNEUMONIAE; TOMOGRAPHY, X-RAY COMPUTED; WEGENER GRANULOMATOSIS;

EID: 33750062286     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-006-9022-x     Document Type: Article

References (18)

1. Bang LM, Keating GM. Adalimumab: a review of its use in rheumatoid arthritis. BioDrugs 2004;18(2):121-39.
2. Tak PP. Effects of infliximab treatment on rheumatoid synovial tissue. J Rheumatol Suppl 2005 Mar;74:31-4.
3. Van der Heijde D, Dijkmans B, et al. Ankylosing spondylitis study for the evaluation of recombinant infliximab therapy study group. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 2005 Feb;52(2):582-91.
4. Sandborn WJ. New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease. Rev Gastroenterol Disord 2005 Winter;5(1):10-8.
5. Kleinert J, Lorenz M, Kostler W, et al. Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade. Wien Klin Wochenschr 2004 May 31;116(9-10):334-8.
6. Hellmich B, Lamprecht P, Gross WL. Advances in the therapy of Wegener's granulomatosis. Curr Opin Rheumatol 2006 Jan;18(1):25-32.
7. Allanore Y, Sellam J, Batteux F, et al. Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab. Clin Exp Rheumatol 2004 Nov-Dec;22(6):756-8.
8. Hegde N, Gayomali C, Rich MW. Infliximab-induced headache and infliximab-induced meningitis: two ends of the same spectrum? South Med J 2005 May;98(5):564-6.
9. Bowie VL, Snella KA, Gopalachar AS, Bharadwaj P. Listeria meningitis associated with infliximab. Ann Pharmacother 2004 Jan;38(1):58-61.
10. Kashyap AS, Kashyap S. Infliximab-induced aseptic meningitis. Lancet 2002 Apr 6;359(9313):1252.
11. Batsis JA, Phy MP. West Nile virus meningitis in a chronic immunosuppressed patient with rheumatoid arthritis. Clin Rheumatol 2005 Sep;24(5):548-50. Epub 2005 Apr 23.
12. Marotte H, Charrin JE, Miossec P. Infliximab-induced aseptic meningitis. Lancet 2001 Nov 24;358(9295):1784.
13. Dayer JM, Beutler B, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985 Dec 1;162(6):2163-8.
14. Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986 Aug 7-13;322(6079):547-9.
15. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001 Oct 11;345(15):1098-104.
16. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981 Aug;30(2):239-45.
17. Furst DE, Breedveld FC, Kalden JR, et al. Updated consensus statement on biological agents, specifically tumour necrosis factor-α (TNF-α) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004. Ann Rheum Dis 2004 Nov;63(Suppl. 2):ii2-ii12.
18. Hyrich KL, Silman AJ, Watson KD, Symmons DP. Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety. Ann Rheum Dis 2004 Dec;63(12):1538-43.